Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SS-LUP-332 for Muscle Performance: Research Compound Comparison

The table below compares SS-LUP-332 for muscle performance against other research peptides used in metabolic and performance studies, showing differences in mechanism, primary research applications, and observed effects in published models. SS-LUP-332 ERRα/ERR

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below compares SS-LUP-332 for muscle performance against other research peptides used in metabolic and performance studies, showing differences in mechanism, primary research applications, and observed effects in published models.
  • SS-LUP-332
  • ERRα/ERRγ agonist. Increases mitochondrial biogenesis and oxidative metabolism
  • Endurance adaptation, metabolic disease models, mitochondrial dysfunction
  • 70% increase in endurance time-to-exhaustion, 40% higher mitochondrial density, improved lactate clearance
  • Estrogen-related receptor alpha and gamma
  • Best tool for studying metabolic remodeling independent of training stimulus. Produces exercise-like adaptations without requiring physical activity input
  • AICAR
  • AMPK activator. Mimics AMP to trigger energy depletion response
  • Glucose metabolism research, AMPK pathway studies
  • Increased glucose uptake, fatty acid oxidation, modest endurance improvement (20–30%)
  • AMP-activated protein kinase
  • Narrow mechanism focused on AMPK. Doesn't address mitochondrial biogenesis as comprehensively as ERR agonists
  • GW501516
  • PPARδ agonist. Upregulates fatty acid oxidation genes
  • Lipid metabolism research, endurance studies
  • Increased fat oxidation, 50% endurance improvement, no effect on mitochondrial density
  • Peroxisome proliferator-activated receptor delta
  • Strong for substrate utilization studies but lacks mitochondrial proliferation effects. Complements rather than replaces ERR agonists
  • Mots-C
  • Mitochondrial-derived peptide. Regulates nuclear gene expression
  • Aging research, mitochondrial signaling, metabolic health
  • Improved insulin sensitivity, increased mitochondrial function in aged muscle
  • Folate cycle enzymes, AMPK (indirect)
  • Addresses mitochondrial-nuclear communication rather than direct metabolic reprogramming. Works through different pathway than SS-LUP-332